IDEAS home Printed from https://ideas.repec.org/a/sae/medema/v24y2004i2p181-191.html
   My bibliography  Save this article

HIV Prevention, Cost-Utility Analysis, and Race/Ethnicity: Methodological Considerations and Recommendations

Author

Listed:
  • David R. Holtgrave

Abstract

In this methodological article, the author reviews 1) the disproportionate impact that HIV/AIDS is having on communities of color in the United States, 2) what is known about the cost-effectiveness of HIV prevention interventions for racial/ethnic minority communities (including the methods used in these studies), and 3) the relative lack of methodological guidance in the field for conducting economic evaluation studies specifically for communities of color. The author finds that race/ethnicity affects cost-utility analyses in several heretofore unrecognized ways. In this article, methodological techniques to address these concerns are proposed. In particular, the author recommends cost-utility analytic strategies that maximize comparability among studies and avoid the introduction of methodological discrimination.

Suggested Citation

  • David R. Holtgrave, 2004. "HIV Prevention, Cost-Utility Analysis, and Race/Ethnicity: Methodological Considerations and Recommendations," Medical Decision Making, , vol. 24(2), pages 181-191, March.
    • Handle: RePEc:sae:medema:v:24:y:2004:i:2:p:181-191
    DOI: 10.1177/0272989X04263342
    as

    Download full text from publisher

    File URL: https://journals.sagepub.com/doi/10.1177/0272989X04263342
    Download Restriction: no
    File URL: https://libkey.io/10.1177/0272989X04263342?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Holtgrave, D.R. & Kelly, J.A., 1996. "Preventing HIV/AIDS among high-risk urban women: The cost-effectiveness of a behavioral group intervention," American Journal of Public Health, American Public Health Association, vol. 86(10), pages 1442-1445.
    2. Alan Williams, 2001. "The ‘fair innings argument’ deserves a fairer hearing! comments by Alan Williams on Nord and Johannesson," Health Economics, John Wiley & Sons, Ltd., vol. 10(7), pages 583-585, October.
    3. Pinkerton, S.D. & Holtgrave, D.R. & DiFranceisco, W.J. & Stevenson, L.Y. & Kelly, J.A., 1998. "Cost-effectiveness of a community-level HIV risk reduction intervention," American Journal of Public Health, American Public Health Association, vol. 88(8), pages 1239-1242.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Ana P. Johnson-Masotti & Purushottam W. Laud & Raymond G. Hoffmann & Matthew J. Hayat & Steven D. Pinkerton, 2001. "Probabilistic Cost-Effectiveness Analysis of HIV Prevention," Evaluation Review, , vol. 25(4), pages 474-502, August.
    2. Steven D. Pinkerton & Harrell W. Chesson & David R. Holtgrave & William Kassler & Peter M. Layde, 2000. "When is an HIV Infection Prevented and when is it Merely Delayed?," Evaluation Review, , vol. 24(3), pages 251-271, June.
    3. Nord, Erik, 2005. "Concerns for the worse off: fair innings versus severity," Social Science & Medicine, Elsevier, vol. 60(2), pages 257-263, January.
    4. Louise B. Russell, 2004. "Is Cost-Effectiveness Analysis Unfair?," Medical Decision Making, , vol. 24(2), pages 232-234, March.
    5. Stephanie Earnshaw & Katherine Hicks & Anke Richter & Amanda Honeycutt, 2007. "A linear programming model for allocating HIV prevention funds with state agencies: a pilot study," Health Care Management Science, Springer, vol. 10(3), pages 239-252, September.
    6. Juan Manuel Cabasés Hita & Eduardo Sánchez Iriso, 2002. "Costs and Effectiveness of a syringe distribution and needle exchange programme for HIV prevention in a regional setting," Documentos de Trabajo - Lan Gaiak Departamento de Economía - Universidad Pública de Navarra 0204, Departamento de Economía - Universidad Pública de Navarra.
    7. Adam Oliver, 2004. "Prioritizing Health Care: Is “Health†Always an Appropriate Maximand?," Medical Decision Making, , vol. 24(3), pages 272-280, June.
    8. Andrew M. Jones (ed.), 2012. "The Elgar Companion to Health Economics, Second Edition," Books, Edward Elgar Publishing, number 14021.
    9. Kathleen J. Sikkema, 2005. "HIV Prevention among Women in Low-Income Housing Developments: Issues and Intervention Outcomes in a Place-Based Randomized Controlled Trial," The ANNALS of the American Academy of Political and Social Science, , vol. 599(1), pages 52-70, May.
    10. Ana P. Johnson-Masotti & Purushottam W. Laud & Raymond G. Hoffmann & Matthew J. Hayat & Steven D. Pinkerton, 2004. "A Bayesian Approach to Net Health Benefits: An Illustration and Application to Modeling HIV Prevention," Medical Decision Making, , vol. 24(6), pages 634-653, November.
    11. Juan Cabasés & Eduardo Sánchez, 2003. "Costs and effectiveness of a syringe distribution and needle exchange program for HIV prevention in a regional setting," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 4(3), pages 203-208, September.
    12. Michael Drummond, 2012. "Economic Evaluation and Decision-makers," Chapters, in: Andrew M. Jones (ed.), The Elgar Companion to Health Economics, Second Edition, chapter 54, Edward Elgar Publishing.
    13. Steven D. Pinkerton & David R. Holtgrave & Laura C. Leviton & David A. Wagstaff & Paul R. Abramson, 1998. "Model-Based Evaluation of Hiv Prevention Interventions," Evaluation Review, , vol. 22(2), pages 155-174, April.
    14. Melchior, Lisa A. & Huba, G. J. & Brown, Vivian B. & Slaughter, Ruth, 1999. "Evaluation of the effects of outreach to women with multiple vulnerabilities on entry into substance abuse treatment," Evaluation and Program Planning, Elsevier, vol. 22(3), pages 269-277, August.
    15. Margaret Brandeau & Gregory Zaric, 2009. "Optimal investment in HIV prevention programs: more is not always better," Health Care Management Science, Springer, vol. 12(1), pages 27-37, March.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:sae:medema:v:24:y:2004:i:2:p:181-191. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: SAGE Publications (email available below). General contact details of provider: .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.